However, the same cells exhibited a significant decrease in SIRT1 (Fig. 2B,C) and BCL2 proteins (Fig. 2G,H), compared with HF-treated cells (p < 0.05 for all treatment vs HF cells and vs hsa-miR34a). The gene discussed is BCL2; the disease is hydrops fetalis.